EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H21N |
| Net Charge | 0 |
| Average Mass | 239.362 |
| Monoisotopic Mass | 239.16740 |
| SMILES | C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 |
| InChI | InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1 |
| InChIKey | YXKTVDFXDRQTKV-HNNXBMFYSA-N |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | sympathomimetic agent A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. dopamine uptake inhibitor A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake. adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. |
| Applications: | appetite depressant Any agent that is used to decrease appetite. sympathomimetic agent A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. dopamine uptake inhibitor A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake. adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. central nervous system stimulant Any drug that enhances the activity of the central nervous system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| benzphetamine (CHEBI:3044) has role adrenergic uptake inhibitor (CHEBI:35640) |
| benzphetamine (CHEBI:3044) has role appetite depressant (CHEBI:50507) |
| benzphetamine (CHEBI:3044) has role dopamine uptake inhibitor (CHEBI:51039) |
| benzphetamine (CHEBI:3044) has role sympathomimetic agent (CHEBI:35524) |
| benzphetamine (CHEBI:3044) is a amphetamines (CHEBI:35338) |
| benzphetamine (CHEBI:3044) is a tertiary amine (CHEBI:32876) |
| Incoming Relation(s) |
| benzphetamine hydrochloride (CHEBI:59169) has part benzphetamine (CHEBI:3044) |
| IUPAC Name |
|---|
| (2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine |
| INNs | Source |
|---|---|
| benzfetamina | ChemIDplus |
| benzfetaminum | ChemIDplus |
| benzfetamine | KEGG DRUG |
| Synonyms | Source |
|---|---|
| Benzphetamine | KEGG COMPOUND |
| benzylamphetamine | DrugBank |
| N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine | DrugBank |
| (S)-benzphetamine | ChEBI |
| (+)-benzphetamine | ChEBI |
| (S)-(+)-benzphetamine | ChEBI |